IDIVX
Price
$23.90
Change
+$0.23 (+0.97%)
Updated
Sep 11 closing price
Net Assets
856.95M
RMFCX
Price
$63.49
Change
+$0.33 (+0.52%)
Updated
Sep 11 closing price
Net Assets
117.47B
Interact to see
Advertisement

IDIVX vs RMFCX

IDIVX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
IDIVX vs. RMFCX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDIVX is a Hold and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. IDIVX (857M). IDIVX pays higher dividends than RMFCX: IDIVX (2.33) vs RMFCX (1.15). IDIVX was incepted earlier than RMFCX: IDIVX (14 years) vs RMFCX (24 years). IDIVX (1.40) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 30.00 vs. IDIVX (27.86). RMFCX has a lower initial minimum investment than IDIVX: RMFCX (250) vs IDIVX (1000). IDIVX annual gain was more profitable for investors over the last year : 19.96 vs. RMFCX (4.75). IDIVX return over 5 years is better than : 83.26 vs. RMFCX (35.61).
IDIVXRMFCXIDIVX / RMFCX
Total Expense Ratio0.950.91104%
Annual Report Gross Expense Ratio1.400.91154%
Fund Existence14 years24 years-
Gain YTD20.9898.539246%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets857M117B1%
Annual Yield % from dividends2.331.15203%
Returns for 1 year19.964.75420%
Returns for 3 years66.0835.38187%
Returns for 5 years83.2635.61234%
Returns for 10 years138.7294.16147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABSYX28.430.20
+0.71%
American Beacon Small Cp Val Y
FFBGX42.740.01
+0.02%
American Funds Global Balanced 529-F-3
ABWCX16.38N/A
N/A
AB All Market Total Return C
SBASX14.25N/A
N/A
Segall Bryant &Hamill Small Cap Cre Ins
FCEUX21.84N/A
N/A
Franklin U.S. Core Equity Advisor